Is SLS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SLS. It does not provide personalized investment advice.

SLS (SELLAS) Stock Analysis - Financials

SELLAS (SLS) is a publicly traded Healthcare sector company. As of September 4, 2026, SLS trades at $13.59 with a market cap of $2.86B and a P/E ratio of -54.56. SLS moved -0.83% today. Year to date, SLS is +214.94%; over the trailing twelve months it is +669.66%. Its 52-week range spans $0.85 to $15.88. Analyst consensus is buy with an average price target of $27.50. Rallies surfaces SLS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are SLS's key financials?

SLS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SLS recently traded at $13.59. Market cap is $2.86B. P/E ratio is -54.56. Revenue is $0.

SLS Key Metrics

Key financial metrics for SLS
Metric	Value
Price	$13.59
Market Cap	$2.86B
P/E Ratio	-54.56
EPS	$-0.25
Dividend Yield	0.24%
52-Week High	$15.88
52-Week Low	$0.85
Volume	97.94K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-26.86M
Gross Margin	0.00%

SLS Analyst Consensus

2 analysts cover SLS: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $27.50.

Common questions about SLS

What are SLS's key financials?: SLS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SLS recently traded at $13.59. Market cap is $2.86B. P/E ratio is -54.56. Revenue is $0.
Is SLS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SLS. It does not provide personalized investment advice.